Irish-domiciled alternatives to SCHD — UCITS dividend ETFs compared

What SCHD actually is

SCHD is the Schwab U.S. Dividend Equity ETF: US-domiciled, expense ratio 0.06%, distributing quarterly. It tracks the Dow Jones U.S. Dividend 100, which requires 10 or more consecutive years of dividend payments and then screens the survivors on cash-flow-to-debt, return on equity, yield and dividend growth. That composite — longevity first, then quality and yield together — is the reason SCHD's yield has historically sat in the 3–4% range while its holdings still look like a quality portfolio rather than a yield trap. It is also a US-situs asset, and retail investors in the EEA and the UK generally cannot buy it, because it publishes no PRIIPs KID.

Both properties — the high yield and the US domicile — are why the wrapper question is sharper for SCHD than for a broad index fund. More on that below.

The nearest Irish-domiciled funds, side by side

These are comparisons of intent, not of holdings. Each fund below is Irish-domiciled and UCITS, so each solves the availability and estate problems the same way — but each screens US dividend payers differently, and none of the three reproduces SCHD's index.

Fund data as published by the issuers and fund data providers in September 2026. TERs and yields move — the factsheet is the authority, not this page.

FUSD is the closest analogue in spirit: like SCHD's index, it wants quality and income at the same time, on US large caps. Its yield is lower than SCHD's, so an income investor swapping one for the other is accepting a smaller dividend stream in exchange for the wrapper.

DGRA answers a slightly different question. Its quality and dividend-growth tilt produces holdings that look more growth-flavoured than SCHD's, with a noticeably lower current yield. If what drew you to SCHD was the yield today, DGRA is the furthest of the three from it; if it was the dividend trajectory, it is the nearest.

UDVD gets closest to SCHD's yield, but through a different door: the S&P High Yield Dividend Aristocrats index requires 20 or more consecutive years of raised dividends — a longevity screen, where SCHD's index applies a quality composite after a shorter 10-year hurdle. Longevity screens and quality composites disagree about real companies, so expect the holdings to differ more than the yields do.

Why the wrapper matters more here than for an S&P 500 fund

Withholding tax is charged on dividends, so its cost scales with yield. A fund yielding 1.3% leaks a little to withholding; a fund yielding 3.5% leaks nearly three times as much on the same capital. For a dividend strategy, the wrapper is not a rounding error on the fee comparison — it can be the largest single number in it.

The mechanics are the same as for any US-versus-Irish pair. SCHD is a US fund: it pays no withholding internally on its US dividends, but its distribution to you is US-source income, withheld at your residence's treaty rate — 30% with no treaty. An Irish fund holding the same kind of US stocks suffers 15% US withholding inside the fund under the US–Ireland treaty, and Ireland withholds nothing from non-resident holders on the way out. Because these funds hold essentially only US stocks, essentially the whole dividend is US-sourced — there is no foreign slice to complicate the comparison.

A worked example, with its assumptions in the open

$100,000 invested; gross dividend yield assumed at 3.5% — inside SCHD's historical range, higher than the Irish funds above would currently pay, but the point is to compare wrappers on the same stream. That is $3,500 of gross dividends a year, essentially all US-source. The Irish-fund column assumes the treaty 15% suffered inside the fund; the SCHD column applies your residence's rate to the distribution.

Now set that against the fee gap. The Irish funds charge 0.25–0.35% against SCHD's 0.06% — roughly $190–290 a year on $100,000. For a no-treaty residence, the ≈$525 withholding advantage of the UCITS dwarfs its higher TER: the wrapper wins even after paying four to six times SCHD's fee. At a 15% treaty rate the withholding columns are equal and SCHD's lower fee wins the annual drag — if you can buy it, and if you can live with the estate exposure below. At 10% or 0%, SCHD wins on withholding too. Find your residence's rate — it is a published number, not an estimate.

One nuance the table cannot show: the two kinds of withholding are not equally recoverable. The tax withheld from a distribution paid to you — the SCHD column — is often creditable against tax at home, where your residence taxes dividends and grants foreign tax credits. The 15% suffered inside a UCITS generally is not: it never appears on any document addressed to you, and most credit systems have nothing to attach it to. A residence that taxes dividends and credits US withholding can therefore absorb much of SCHD's apparent disadvantage; a residence that taxes nothing gets no credit for anything, which is why the no-treaty, no-income-tax case is where the UCITS advantage is widest and most permanent.

Estate tax: the asymmetry that is not about percentages

SCHD is a US-situs asset. For a non-US, non-resident estate, US-situs assets above USD 60,000 can attract US estate tax at rates reaching 40% on the excess, unless an estate tax treaty raises that threshold — and the United States has estate treaties with only a limited number of countries. The Irish-domiciled funds on this page are not US-situs assets for this purpose, whatever they hold.

A dividend portfolio built to be held for decades crosses $60,000 early and stays across it. Whether the exposure ever bites depends on how the assets are held and on the circumstances of an estate — not something any tracker can compute — but a strategy designed around never selling should know which side of the line its wrapper is on.

If the dividend stream is the point

SCHD is usually held by people who want the income, not just the exposure — which changes what the numbers above mean. The distributing UCITS classes (FUSD, UDVD, and DGRA's distributing sibling) pay their dividends to non-resident holders with no Irish withholding on the way out, so what the table calls a per-year difference is a difference in cash received, every year. For a portfolio built around the dividend stream, that gap compounds: income lost to withholding is income never reinvested, and the shortfall grows with the portfolio rather than staying a fixed annual figure.

The other side of the same coin: the Irish funds' lower headline yields are not only a screen difference. On the same $100,000, a fund yielding 2.5% after the wrapper advantage can still deliver less cash than SCHD yielding 3.5% after a 15% treaty withholding. Compare the after-withholding income on your own residence's rate, not the headline yields.

What to do once you have chosen

Both effects on this page are invisible on a brokerage statement. Fund-level withholding never appears anywhere — it is deducted before the fund is paid — and investor-level withholding shows up as a line you notice once and forget. BorderFolio estimates both steps per instrument, using the domicile of each fund you actually hold against the tax residence you configure, and keeps the estimate attached to your real dividend history rather than to a hypothetical portfolio. For a dividend strategy, where withholding is the largest recurring leak, that is the difference between knowing your income and guessing it.

Limitations

• None of these funds is SCHD. Different indices, different screens, different holdings, different yields. This page compares intent and wrappers; it cannot tell you the funds will behave alike.
• The example is an illustration, not your portfolio. The 3.5% yield is an assumption inside SCHD's historical range; yields, TERs and index rules move, and the factsheets govern.
• Treaty rates depend on paperwork. Without valid documentation on file the statutory 30% applies whatever the treaty table says.
• The second step is not modelled here. Tax where you live, foreign tax credits and their caps, and the treatment of accumulating share classes are all residence-specific.
• Not advice. This is an informational comparison of fund structures, not a recommendation to buy or sell any of them. See the investment & tax disclaimer.